Lymphosarcoma, also referred to as lymphoma, is a common and serious cancer in dogs, primarily targeting lymphocytes—an important type of white blood cell—and the lymphoid tissues including lymph nodes, spleen, liver, bone marrow, and gastrointestinal tract. This cancer can affect dogs of any age, breed, or sex but is most frequently diagnosed in middle-aged to older dogs.
Certain breeds are more predisposed to developing lymphosarcoma, likely due to genetic factors. These breeds include the Bouvier des Flandres puppies, Irish Water Spaniel puppies, Golden Retriever puppies, Boxer puppies, German Shepherd puppies, West Highland Terrier puppies, and Pointers puppies. Responsible breeders carefully screen their breeding stock to reduce inherited health risks, promote genetic diversity, and ensure the wellbeing of puppies.
While most cases occur between six and nine years of age, lymphosarcoma can affect dogs at any life stage. Early veterinary attention and regular health checks can improve outcomes.
Though the precise cause of lymphosarcoma remains unclear, research indicates that a combination of genetic predisposition, environmental triggers, and immune system factors may play roles. Studies continue to investigate why some breeds are more vulnerable, but current understanding emphasises the importance of routine health monitoring and early detection rather than fear of breed alone.
There are several types of lymphosarcoma depending on the primary site of tumour development, each presenting with distinct clinical signs:
This is the most common form, involving one or more external lymph nodes such as under the neck, in front of the shoulders, or behind the knees. Dogs may show:
Affecting the stomach and intestines, symptoms often include:
This type involves lymphoid tissues in the chest, leading to:
Known as cutaneous lymphosarcoma, it causes skin symptoms such as:
Other organs including the liver, spleen, lymph nodes, and bone marrow may also be affected.
When bone marrow is involved, it leads to leukaemia with symptoms such as:
Diagnosing lymphosarcoma requires a comprehensive approach. Veterinarians typically perform:
Advanced diagnostic techniques such as flow cytometry and PCR for antigen receptor rearrangement (PARR) are valuable to classify lymphoma subtypes for better prognostication.
Chemotherapy remains the mainstay treatment for canine lymphosarcoma. It can induce remission by reducing or eliminating tumours, significantly improving quality of life, though remission does not equal cure. Treatment regimens usually involve weekly sessions over a six-month period, monitored closely by your veterinary team.
Vets may adjust drugs during treatment cycles to prevent resistance and reduce side effects. Most dogs tolerate chemotherapy well, but some may experience mild symptoms such as decreased appetite, lethargy, nausea, or vomiting. Immediate veterinary advice is crucial if concerns arise.
Complementary supportive care includes proper nutrition, hydration, and pain management to maintain your dog’s wellbeing throughout treatment.
While prognosis varies widely depending on lymphoma type, stage, and response to therapy, many dogs enjoy months to years of good-quality life with appropriate treatment. Regular veterinary check-ups, monitoring for new symptoms, and adjustments in therapy are essential components of care.
Providing a loving, stress-free environment and promptly addressing health concerns supports your dog’s comfort and happiness through their journey.
Lymphosarcoma is a challenging diagnosis—but early veterinary evaluation and treatment can make a meaningful difference. Responsible breeding, ongoing health monitoring, and quick attention to changes in your dog’s health are powerful tools in managing this disease.
If you have concerns about your dog’s lymph nodes, appetite, energy, or other symptoms, consult your vet promptly. Your informed care and compassion are key to supporting your canine companion through every moment.